Share this page!

Enter URL or ID to Unroll

You can paste full URL like: https://x.com/threadreaderapp/status/1644127596119195649
or just the ID like: 1644127596119195649

How to get URL link on X (Twitter) App

  1. On the Twitter thread, click on or icon on the bottom
  2. Click again on or Share Via icon
  3. Click on Copy Link to Tweet
  4. Paste it above and click "Unroll Thread"!
  5. More info at Twitter Help
Jammer Profile picture
@acrossthemersey
Oct 25, 2024 • 1 tweets • 1 min read • Read on X
Researchers from a university in Brazil found that COVID increased the risk of having an ischemic stroke, or stroke caused by a blood vessel blockage, by 76%.

It’s hard to imagine reading that and not trying to avoid reinfection.
benefitspro.com/2024/10/25/yes…Yes, COVID does increase stroke risk, researchers find

• • •

Missing some Tweet in this thread? You can try to force a refresh
　

Keep Current with Jammer

Jammer Profile picture

Stay in touch and get notified when new unrolls are available from this author!

Read all threads

This Thread may be Removed Anytime!

PDF

Twitter may remove this content at anytime! Save it as PDF for later use!

Try unrolling a thread yourself!

how to unroll video
  1. Follow @ThreadReaderApp to mention us!

  2. From a Twitter thread mention us with a keyword "unroll"
@threadreaderapp unroll

Practice here first or read more on our help page!

More from @acrossthemersey

Jammer Profile picture
Jan 30
New study from Japan found after reclassifying COVID to a lower alert level, reported infections dropped sharply due to reduced testing, but wastewater continued detecting high viral loads, revealing invisible community spread including asymptomatic cases missed by testing alone. Sewage monitoring uncovers 'invisible' COVID- 19 cases missed by testing University of Osaka edited by Lisa Lock, reviewed by Andrew Zinin SARS-COV-2 RNA concentrations in wastewater, and community-acquired infection cases and hospital-acquired infections reported at a university hospital. Credit: Environment International (2026). DOI: 10.1016/j.envint.2025.110028
This is the kind of thing that occasionally crosses your mind while hospitalized for 5 days, but there’s not much you can do but trust your own N95.
medicalxpress.com/news/2026-01-s…
I woke up to being Quoted by Blue Maga blaming President Trump. This study analyzed changes in 2023. In the United States, we stopped mandatory reporting then downgraded it in 2024. Who was President when these policies went into effect?

You people are a societal plague. Image
Image
Read 4 tweets
Jammer Profile picture
Jan 28
Gastroenterology as a specialty should be obliterated. Not all GI Drs. are bad, but the practice only looks for things to rule out rather than problem solving. The only reason I’m home from the hospital is because of the Emergency Room MD, an Internist and the nursing staff.
When I got to the ER it was so bad that I could not give an honest recount of that day, but the ER Dr. got me in for scans almost immediately, put me on heavy duty pain injections and said I should be admitted - zero chance that I could go home. Friday was a complete blur.
I came to on Saturday and my dad showed up, wearing an actual mask, so I assumed I had passed on into the IACC nothing new afterlife, but no.

Finally a really nice internist prescribed an Rx called Carafate, which is a GI med to treat ulcers, and she continued my pain med.
Read 11 tweets
Jammer Profile picture
Jan 8
The National Bureau of Economic Research analyzed death certificates and wage data, concluding workers substantially underestimate the COVID mortality risk compared to other job related mortality (Value of Statistical Life), likely due to being uninformed and job market pressure. DO WORKERS UNDERVALUE COVID-19 RISK? EVIDENCE FROM WAGES AND DEATH CERTIFICATE DATA Cong T. Gian Sumedha Gupta Kosali I. Simon Ryan Sullivan Coady Wing Working Paper 33031 http://www.nber.org/papers/w33031 NATIONAL BUREAU OF ECONOMIC RESEARCH 1050 Massachusetts Avenue Cambridge, MA 02138 ABSTRACT When mortality risks of a job increase, economic theory predicts that wages will rise to compensate workers. COVID-19 became a new source of mortality risk from close contact with other workers and customers. The results are consistent with workers substantially underestimating or undervaluin...
Peer reviewed & published in 2025, Journal of Risk & Uncertainty:


Not sure you can access the working paper w/o an institutional email, so here’s a key excerpt stating this is a first, highly relevant and new-future data will be used for economic policy. link.springer.com/article/10.100…This study fills an important gap in the literature by providing updated estimates of the COVID-19 mortality risk-based wage premiums arising from new workplace risks, and the implied value of statistical life. In addition, we introduce a new and practical alternative dataset for researchers to use in future workplace mortality studies. While the findings presented here are somewhat preliminary due to the short time-period analyzed, we view them as a major first step for how to precisely measure COVID-19 fatality risks and their associated compensating wage differentials on the job. As new...
The NBER published this paper last year as well, which is directly correlated. Over $200 Billion (likely upwards of $220B) has been saved in future Social Security payments due to excess COVID deaths just between 2020-2023, which improved SSA financial health.
Read 4 tweets
Jammer Profile picture
Jan 5
A new CDC study published in JAMA today, shows COVID is still killing a substantial number of Americans, with over 100K deaths annually between 2022-2024.

‘Although the Public Health Emergency ended, this study suggests it remains a major driver of mortality among older adults.’ HEALTH Covid-19 Is Still Killing a Disturbing Number of Americans, Study Finds Between 2022 and 2024, covid-19 killed roughly 100,000 Americans annually, new research by CDC scientists shows. PUBLISHED JANUARY 5, 2026
Article:
gizmodo.com/covid-19-is-st…

Study:
jamanetwork.com/journals/jamai… Image
We did it Joe! We killed hundreds of thousands of people after the orange guy left and blue maga doesn’t give a shit because they’re red maga in blue hats.
bu.edu/articles/2022/…
Read 5 tweets
Jammer Profile picture
Dec 14, 2025
Meta analysis of 429 studies and 2M people found a 36% pooled prevalence of LongCOVID globally.

29% rate among non-hospitalized with memory issues, muscle weakness, dyspnea, joint pain the most common symptoms. Stratified by year, prevalence was still 34% in 2024 v 38% in 2021. Image
Alt text didn’t save;

More Than One-Third of Individuals With COVID-19

Experience Long COVID
Jessica Nye, PhD |

Systematic review and meta-analysis published in Open Forum Infectious Diseases reported a pooled prevalence of long COVID as 36% worldwide.
A total of 429 studies
They once again highlight the urgent need for biomarkers and effective treatments, nothing about “more advocacy.”
thecardiologyadvisor.com/news/more-than…
Read 4 tweets
Jammer Profile picture
Dec 12, 2025
There are several healthcare industry reports showing various sales trends with data driven factors provided.

The latest is loss of taste and smell (anosmia) expecting to reach $4.1B by 2034 with increasing LongCOVID cases and viral infections (COVID) being the major catalysts. Press release Chronic Smell and Flavor Loss Market Size to Reach USD 4.1 Billion by 2034 12-12-2025 07:26 AM CET | Health & Medicine Press release from: Exactitude Consultancy
Forecast Outlook The market is expected to maintain steady growth as healthcare providers integrate advanced diagnostics, sensory rehabilitation therapies, and personalized treatment pathways. Increasing cases of long-COVID-related smell and taste impairment remain a major catalyst for sustained market demand through 2034. Market Overview Chronic smell and flavor loss conditions-anosmia, hyposmia, ageusia, and hypogeusia-are becoming increasingly recognized as significant health burdens. The surge in sensory impairment cases following viral infections (especially COVID-19), coupled with in...
Even for those without login credentials, the summary repeatedly explains that North America makes up 42% of this trend and they use terms like “rising post COVID” and “surge post infection (COVID)”.

These data drive the push to spend on new diagnostics and therapeutics. Image
Research based on this continued growth (if you want to call it that) is driving collaboration between universities, AI and pharmaceutical.

Seems odd that if LongCOVID rates were “decreasing” and COVID was no biggie, you’d see this type of market strategy and spending. Recent Market Developments • Introduction of AI-driven olfactory test kits for remote diagnosis. • Research collaborations between universities and pharmaceutical companies for developing regenerative smell therapies. • Telehealth platforms integrating smell/taste screening tools for long-COVID management. Key Players Leading companies influencing the market include: Nestlé S.A., Procter & Gamble, Unilever, Johnson & Johnson, PepsiCo, Coca-Cola, Campbell Soup, Reckitt Benckiser, Kraft Heinz, and Tata Consumer Products, among others. Market Drivers • Rising global prevalence of anosmia and...
Read 4 tweets

Did Thread Reader help you today?

Support us! We are indie developers!

This site is made by just two indie developers on a laptop doing marketing, support and development! Read more about the story.

Become a Premium Member ($3/month or $30/year) and get exclusive features!

Become Premium

Don't want to be a Premium member but still want to support us?

Make a small donation by buying us coffee ($5) or help with server cost ($10)

Donate via Paypal

Or Donate anonymously using crypto!

Ethereum

0xfe58350B80634f60Fa6Dc149a72b4DFbc17D341E copy

Bitcoin

3ATGMxNzCUFzxpMCHL5sWSt4DVtS8UqXpi copy

Thank you for your support!

Follow Us!

Send Email!

:(